These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27506128)

  • 21. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
    Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
    J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease diagnosis based on the Hippocampal Unified Multi-Atlas Network (HUMAN) algorithm.
    Amoroso N; Rocca M; Bellotti R; Fanizzi A; Monaco A; Tangaro S;
    Biomed Eng Online; 2018 Jan; 17(1):6. PubMed ID: 29357893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
    Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
    J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
    Mangialasche F; Westman E; Kivipelto M; Muehlboeck JS; Cecchetti R; Baglioni M; Tarducci R; Gobbi G; Floridi P; Soininen H; Kłoszewska I; Tsolaki M; Vellas B; Spenger C; Lovestone S; Wahlund LO; Simmons A; Mecocci P;
    J Intern Med; 2013 Jun; 273(6):602-21. PubMed ID: 23343471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.
    Falahati F; Ferreira D; Soininen H; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Lovestone S; Eriksdotter M; Wahlund LO; Simmons A; Westman E;
    Brain Topogr; 2016 Mar; 29(2):296-307. PubMed ID: 26440606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI.
    Teipel SJ; Wohlert A; Metzger C; Grimmer T; Sorg C; Ewers M; Meisenzahl E; Klöppel S; Borchardt V; Grothe MJ; Walter M; Dyrba M
    Neuroimage Clin; 2017; 14():183-194. PubMed ID: 28180077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.
    Huang M; Yang W; Feng Q; Chen W;
    Sci Rep; 2017 Jan; 7():39880. PubMed ID: 28079104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.
    Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C
    Int J Geriatr Psychiatry; 2011 Jan; 26(1):75-82. PubMed ID: 21157852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fuzzy-based system reveals Alzheimer's Disease onset in subjects with Mild Cognitive Impairment.
    Tangaro S; Fanizzi A; Amoroso N; Bellotti R;
    Phys Med; 2017 Jun; 38():36-44. PubMed ID: 28610695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.
    Eskildsen SF; Coupé P; Fonov VS; Pruessner JC; Collins DL;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1():S23-31. PubMed ID: 25260851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.